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ABSTRACT 
Objective: The aim of this study was to evaluate teratogenicity effect of ethanolic extract of binahong (Anredera cordifolia (Ten.) Steenis) leaves in 
Wistar rats.  
Methods: The teratogenicity test were done in 5 groups of rat i. e. control group, trimethoprim at a dose of 360 mg/kg bw, ethanolic extract of 
binahong at doses of 100, 400, and 1000 mg/kg bw. Test substance was given orally on day 6 to day 15 of rats pregnancy. At day 20 of gestation, 
laparoctomy was performed to retrieve the fetuses. Evaluation was done towards the fetus skeletal, organ and fetal weight.  
Results: Teratogenicity test results showed that there was the ungrowth fetus observed in all groups with the highest incident in trimethoprim 
group (39.5%). Average of fetus body weight of trimethoprim, control, binahong extract at doses of 100, 400 and 1000 mg/kg bw group was 2.32 ± 
0.66 g, 3.58 ± 0.24 g, 3.64 ± 0.26 g, 3.67 ± 0.25 g and 3.93 ± 0.61 g, respectively. Skeletal evaluation showed that there was malformation of sacral 
vertebrae (65.2%), convulated costal stucture (82.6%), palate (33.3%), head cavity (88.9%), nasal cavity (5.6%), eye cavity (5.6%), ear (5.6%) and 
liver (43.1%) which were observed only in trimethoprim group.  
Conclusion: Ethanolic extract of binahong at doses of 100, 400 and 1000 mg/kg bw in rat did not have the teratogenic effect. 
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INTRODUCTION 
Nowadays, traditional medicines are expected to evolve into a 
standardized herbal medicines or phytopharmaca (clinical based 
herbal medicines) class so they can be used in health care facilities. 
Drugs used in health care facilities must meet the requirements of a 
safe, beneficial and have been standardized. Security affirmation 
efforts are necessary to meet the requirements through some 
toxicity and efficacy tests, which will be followed by clinical trials. 
Toxicity testing is divided into two categories. First, the general 
toxicity tests include acute toxicity test (conducted by giving animal a 
single or multiple doses of a test substance for 24-hours period), sub 
chronic toxicity test (conducted by giving animal repeated exposure of 
a test substance, usually for 3-months period), and chronic toxicity test 
(conducted to observe the toxic effects by giving animal long-term 
repeated administration of a test substance usually for 1-year period). 
Second category is special toxicity tests which investigate the 
carcinogenic, mutagenic, and teratogenic effects of a substance [1]. 
Binahong (Anredera cordifolia (Ten.) Steenis) plant is one of the 
plants used in traditional medicines. The leaves of binahong plant 
have been used by most people to treat bacterial infection [2], peptic 
ulcers [3], diabetes [4], and kidney failure [5]. With such properties 
of binahong than it is possible for pregnant women to consume it 
during their pregnancies. However, there has been no publication 
about the teratogenic effects of the use of binahong extracts yet. 
This research was conducted to observe the teratogenic effect of 
ethanolic leaf extracts of binahong in pregnant rats. The results of 
the teratogenic test were expected to be a material consideration in 
its use during pregnancy. 
MATERIALS AND METHODS 
Methods used in this study were based on a OECD toxicity study 
guidelines for testing chemicals and prenatal development [6,7]. 
OECD guidelines are a protocol accepted by animal ethics committee 
in School of Pharmacy, Bandung Institute of Technology. 
Wistar rats were randomly divided into five groups: a control group 
that received 2% tragacanth, comparative controlled group that 
administrated with a dose of 360 mg/kg bw of trimethoprim and three 
experimental groups, each was administrated with 100, 400 and 1000 
mg/kg bw of ethanolic leaf extracts of binahong (in a suspension form 
in 2% tragacanth). The lowest dose used was derived from the 
conversion of therapeutic dose in humans, while the highest dose was 
a limit dose on teratogenicity test. If the embryo toxicity or 
teratogenicity was not found at the highest dose, then it was not 
necessary to test at the other doses. The drug was administered orally 
once daily on day 6 to day 15 of gestation. The drug administration 
period was in the organogenesis phase of rat gestation. 
Determination of early pregnancy 
Female rats were caged with sexually matured male in the ratio of 
two males to three females. The following day, vaginal smear 
examination was performed in female rats. A small amount of saline 
was flushed into the vagina hole of rats using a pipette tip. One or 
two drops of the resulting vaginal fluid contained cell suspension 
then dripped into a slide. As soon as the smears were dried out, they 
were stained with 0.1% methylene blue then examined under a 
microscope using magnification of 400x. Gestational day 0 was 
determined by the presence of vaginal plugs or sperm in vaginal 
smears, as can be seen in fig. 1. 
 
 
Fig. 1: Photomicrograph of rat vaginal smear after copulation. 
There were a lot of sperm in the smear, as shown by the arrow 
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DISSECTION AND OBSERVATION 
On day 19 of gestation, pregnant rats were dissected to retrieve 
fetuses. Each fetus was then dried and weighed. The fresh normal 
fetuses taken from the uterus was shown as in fig. 2. 
 
 
Fig. 2: Fresh fetuses of each group taken out from the uterus 
CT: control group, LD: lower-dose group (100 mg/kg bw), MD: 
middle-dose group (400 mg/kg bw), HD: higher-dose group 
(1000 mg/kg bw), T: trimethoprim group (360 mg/kg bw). 
 
Preparation of skeletal preservation 
Preparation: Fetuses was fixed in 90% ethanol solution for at least 1-2 
weeks. After drying out, fetuses were skinned completely. Eyes and 
blobs of fat on the nape were removed, and the trachea was trimmed. 
Groin legs and underarms were cut out of the body. The abdominal 
wall was opened. After skinning and removing the internal organs, the 
fetuses were transferred back to the fixation bottle. 
Cleaning: After skinning and removing the internal organs, ethanol 
solution was replaced with 0.5% KOH. Cleaning lasted for one day. The 
containers were shaken to remove the air from the chest cavity 
occasionally. 
Bleaching: After purification was considered perfect, KOH solution 
was removed, the fetuses were washed with water and the remains 
fat were removed. The water was then replaced with 1% hydrogen 
peroxide solution. Fetus remained in it for 2-3 hours, shaken 
occasionally. Bleaching was considered perfect if the inner bones 
were in white color. 
Staining: After bleaching, fetuses then washed and soaked in the 
water for approximately 10 minutes. The water was then replaced 
with Alizarin dye solution. Fetus remained in the dye for not more 
than 24 hours. Staining was considered perfect if the skeleton had 
been seen clearly.  
Final cleaning: After staining was considered perfect, alizarin dye 
solution was discarded, the fetuses then were washed out with 
water several times and then gradually immersed in a solution of 
5%, 20%, 40%, 80% glycerol and lastly pure glycerol respectively 
for 1 week each.  
Skeletal evaluation: The evaluation was conducted after the slides 
were immersed in 80% glycerol for at least 1 week. Firstly the 
posterior of fetal skeleton were observed: the skull, spine, ribs were 
examined. The skeletons were then turned over to observe the 
anterior parts: the skeleton of oral cavity, bone wrapped around the 
shoulders and hips, forelimbs and hind limbs. The results of the 
examinations including structure, morphology, number and position 
of the bones were then recorded. 
Soft tissue assessment 
After being fixed in Bouin solution for 1-2 weeks, the fetuses from 
the same dam were collected in a beaker glass filled with water. 
Fetuses then dried and cut up with a particular pattern. The head 
part between the upper and lower jaw was cut using a razor blade, 
and the plate was examined. Cross section was made from the nose 
to the hind at the upper head-cut with a maximum distance of 1 mm 
from the nose, eyes, and lateral ventricles on the priority. Abdominal 
skin was incised with a scalpel, the fore part was cut and removed, 
and the organs inside the abdominal cavity were carefully taken out. 
Condition status of the ureter, genital glands, and bladder was then 
examined. All the abnormalities were recorded. 
Statistical Method and Data Analysis  
Statistical analysis of the results was analyzed with one-way ANOVA 
followed by Bonferroni post hoc analysis. p values <0.05 were 
considered to be significant. 
RESULTS AND DISCUSSION 
The methods used in this study were in vivo methods in rats. Rats 
were divided into 5 groups: a control group that received 2% 
tragacanth, comparative controlled group that administrated with a 
dose of 360 mg/kg bw of trimethoprim and three experimental 
groups, each was administrated with 100, 400 and 1000 mg/kg bw 
of ethanolic leaf extracts of binahong (Anredera cordifolia (Ten.) 
Steenis). The lower-dose (100 mg/kg bw) was based on the previous 
studies which had pharmacological activity [5]. The middle-dose 
(400 mg/kg bw) was derived from conversion of 4 times of the 
lower-dose. The higher-dose (1000 mg/kg bw) is a dose test limit, at 
which if there was not found toxic or teratogenic effects on the 
embryos, then the dose should not be increased or in other words 
the extract used was considered safe. 
 
Table 1: The Number of Live Fetuses, Underdeveloped Fetuses, And Their Body Weight Observations 
Groups Live Fetus Underdeveloped Fetus Average fetal weight 
(grams) Total number % Total number % 
Control 160 97.6 4 2.4 3.58 ± 0.24 
Binahong extract 100 mg/kg bw 166 93.3 12 6.7 3.64 ± 0.26 
Binahong extract 400 mg/kg bw 182 97.3 5 2.7 3.67 ± 0.25 
Binahong extract 1000 mg/kg bw 191 91.8 17 8.2 3.93 ± 0.61* 
Trimethoprim 360 mg/kg bw 118 61.1 77* 39.5 2.32 ± 0.66* 
Note: Statistical calculations of live fetuses, underdeveloped fetuses and fetal weight using ANOVA followed by a Bonferroni’s post hoc test at 
p<0.05, *significantly difference compared to control group.  
 
This study was preceded by the determination of the estrous cycle. 
Proestrus phase was characterized by the presence of nucleated 
epithelial cells, which were more dominant in the vaginal fluid of 
rats examined under the microscope at 400x magnification. After 
that proestrus female rats were mated with male rats and mating 
was confirmed by examining rats’ vaginal smears on the following 
day. After mating was confirmed, pregnancy was determined by the 
presence of vaginal plugs or sperm in vaginal smears. The presence 
of sperms in the vaginal smears was designated as gestation day 0 
(fig. 1). 
Drug and extract were administrated orally during the 
organogenesis period on day 6 to day 15 of gestation daily. 
Organogenesis phase was the most critical period during gestation 
and outside environmental influences could cause teratogenic 
effects. During this phase, the attachment of the blastocyst to the 
uterine wall called implantation occurred, the structure formation 
developed and the cells differentiated into organs very rapidly. 
Increased sensitivity of most tissues during organogenesis caused 
death and disabilities in the embryos easier [8,9]. Laparotomy was 
performed to retrieve the fetuses on day 20 of gestation. 
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Observations were done towards the number of live fetuses, underdeveloped fetuses, and morphological abnormalities. 
 
Table 2: Examination of Vertebral Malformation Occurrence in 20-Day-Old Rat Fetuses 
Groups Total number of fetus Number of fetus observed Malformation occurrence (%) 
Ce T L Sa R 
Control 160 58 0 0 0 0 0 
Binahong extract 100 mg/kg bw 166 63 0 0 0 0 0 
Binahong extract 400 mg/kg bw 182 66 0 0 0 0 0 
Binahong extract 1000 mg/kg bw 191 70 0 0 0 0 0 
Trimethoprim 360 mg/kg bw 118 46 0 0 0 30 (65.2) 38 (82.6) 
Note: Ce: Cervical, T: Thoracic, L: Lumbar, Sa: Sacral, R: Ribs. 
 
Table 3: Examination of Skeletal Limb Completeness in 20-Day-Old Rat Fetuses 
Groups Total number of fetus Number of fetus observed Malformation occurrence (%) 
Forelegs Hind legs 
DP PP Mc FD FP Mt 
Control 160 58 0 0 0 0 0 0 
Binahong extract 100 mg/kg bw 166 63 0 0 0 0 0 0 
Binahong extract 400 mg/kg bw 182 66 0 0 0 0 0 0 
Binahong extract 1000 mg/kg bw 191 70 0 0 0 0 0 0 
Trimethoprim 360 mg/kg bw 118 46 0 0 0 0 0 0 
Note: DP: Distal Phalanges, PP: Proximal Phalanges, Mc: Metacarpal, Mt: Metatarsal. 
 
In number of live fetuses (Table 1), there were 2.4 % 
underdeveloped fetuses observed in the control group. In 
trimethoprim group, there were only 61.1% live fetuses and 39.5% 
out of it were underdeveloped fetuses which statistically significant 
compared to the control group. Meanwhile, in ethanolic extract of 
binahong at doses of 100, 400 and 1000 mg/kg bw, there were 6.7%, 
2.7% and 8.2% respectively underdeveloped fetuses, which was not 
statistically significant compared to control group. It suggests that 
ethanolic extract of binahong does not affect development of the 
fetus.
  







Organs Malformation Occurrence (%) 
Uj No Ey Hc Hr Ln Lv Sm Sp Kd Tt/ 
Ov 
Fl Hl Er Tl 












191 121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Trimethoprim 
360 mg/kg bw 








0 0 31 
(43.1) 
0 0 0 0 0 0 4 
(5.6) 
0 
Note: Uj: upper jaw, No: nose, Ey: eyes, Hc: head cavity, Hr: heart, Ln: lung, Lv: liver, Sm: stomach, Sp: spleen, Kd: kidney, Tt/Ov: testes/ovaries, Fl: 
foreleg, Hi: hind leg, Er: ear, Tl: tail. 
 
Average fetal weight in control,trimethoprim, 100, 400 and 1000 
mg/kg bw of ethanolic leaf extract of binahong groups were 3.58 ± 
0.24 g, 2.32 ± 0.66 g, 3.64 ± 0.26 g, 3.67 ± 0.25 g, and 3.93 ± 0.61 g, 
respectively (Table 1 and fig. 2). Fetal weight of trimethoprim group 
was significantly lower compared to control group. The increase in 
dose of leaf extracts of binahong followed by the increase in fetal 
weight. Dose of 1000 mg/kg bw of ethanolic group showed 
significantly higher compared to control group. 
Evaluation of the fetal skeletons aimed to see the abnormalities in 
the skeletons, which stained with alizarin sulfonate dye solution 
after undergoing the series of processes including cleaning, 
bleaching and final cleaning. Collecting of fetuses for skeletal 
examinations was based on teratogenicity test protocols. Skeletal 
preparation was done from one third of live fetuses. The 
examination included the number and abnormalities of fetal 
skeletons that might be occurred. 
The composition and number of normal vertebral columns are 7 
cervical, 13 thoracic, 6 lumbar and 4 sacral vertebrae. Observations 
of the anterior and posterior column were performed using a 
magnifying glass. The composition and number of normal forelimb 
columns are 5 distal, 4 proximal, and 4 metacarpal, whereas the hind 
limb columns are 5 distal, 4 proximal, and 5 metatarsal [10]. 
Skeletal evaluations in trimethoprim group showed that there were 
abnormalities in form of wavy ribs structure (82.6%), but found no 
abnormality in the number of ribs (Table 2 and fig. 3B). The 
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abnormalities were also found in the sacral (65.2%), in which only 2 
bones were in normal growth while the other 2 bones were 
abnormal (Table 2 and fig. 3C). Malformations observed in skeletal 
evaluation confirmed that trimethoprim might also affect bone 
formation in the fetus during pregnancy, while no abnormality was 
observed in all fetuses in control and 100, 400 and 1000 mg/kg bw 
of ethanolic leaf extract of binahong groups (Table 2 and 3; fig. 3A, 
3B, and 3C). 
 
 
Fig. 3: A. Nomal skeleton. B and C. Skeletal malformations in trimethoprim group. Abnormalities in wavy ribs structure form (B) and 
incomplete sacro-caudal growth (C) were observed. Note: CT: control group, LD: lower-dose group (100 mg/kg bw), MD: middle-dose 
group (400 mg/kg bw), HD: higher-dose group (1000 mg/kg bw), T: trimethoprim group (360 mg/kg bw) 
 
 
Fig. 4: Fetal head section of each group 
 
A: nasal cavity section, B: eye socket section, C: cranial cavity section. Note: CT: control group, LD: lower-dose group (100 mg/kg bw), MD: middle-
dose group (400 mg/kg bw), HD: higher-dose group (1000 mg/kg bw), T: trimethoprim group (360 mg/kg bw).  
 
 
Fig. 5: Organ abnormalities in trimethoprim group                     
 
The incomplete jaw formation was observed in trimethoprim group 
(Fig. 5A and 5B). A: Palate formation was absent. B: Palate formation 
was incomplete. C: Normal palate formation 
Soft tissue or organs examinations in trimethoprim group 
showed some abnormalities such as incomplete upper jaw 
formation, absence of the nasal cavity formation, brain shape 
malformation, absence of eye socket and ears formation and also 
color of liver abnormalities, which were darker than the color of 
control group’s liver (Table 4, fig. 4,5, and 6).Neither control 
group nor experimental groups showed abnormality in organ 
formation.
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Fig. 6: Liver colour abnormalities in trimethoprim group 
Note: T: trimethoprim group, CT: control group. 
 
CONCLUSION 
Ethanolic leaf extracts of binahong (Anredera cordifolia (Ten.) 
Steenis) at doses of 100, 400, 1000 mg/kg bw in pregnant rats did 
not have teratogenic effects like trimethoprim (360 mg/kg bw) as a 
comparative drug. The increase in dose of leaf extracts of binahong 
followed by the increase in fetal weight.  
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